市場調查報告書
商品編碼
1403413
至 2030 年真皮填充劑市場預測:按產品、藥物類型、材料、配銷通路、應用、最終用戶和地區進行的全球分析Dermal Fillers Market Forecasts to 2030 - Global Analysis By Product (Biodegradable, Non-Biodegradable and Other Products), Drug Type, Material, Distribution Channel, Application, End User and By Geography |
根據 Stratistics MRC 的數據,2023 年全球皮膚填充劑市場規模為 55 億美元,預計在預測期內將以 9.8% 的複合年成長率成長,並在 2030 年達到 105 億美元。
真皮填充劑是一種使用凝膠狀材料的微創治療方法。這些用於改善臉部皮膚的外觀,並以注射劑的形式出現。這些治療可減少皺紋,使外表更年輕。這些治療有助於減少痤瘡疤痕,並用於改善嘴唇和臉部的皺紋。
根據世界衛生組織估計,到2030年,全球六分之一的人口將超過60歲。根據統計,老年人口將從2020年的10億增加一倍,達到2050年的21億。
這種治療被稱為微創手術,是使用特殊的手術器械和觀察鏡進行的。它可以減少多餘的脂肪、體積和輪廓,同時專注於細紋和笑紋等臉部異常現象。全球對微創能量緊致皮膚、除皺、臉部塑形和活膚手術的需求很大。因此,微創手術的日益普及預計將推動市場成長。
用於製造永久性真皮填充劑的成分不會被人體消化。因此,身體可能會採取自衛行動,並可能產生感染疾病和生物膜形成等後果。此外,永久性填充劑對人體具有不可逆的危害,且無法去除。人們對使用真皮填充劑的不利影響的日益關注可能會在一定程度上限制市場的發展。
真皮填充劑是一種凝膠狀化合物,注入皮下可撫平細紋、軟化皺紋並補充失去的體積。這些填充劑不需要手術或停工,是看起來更年輕的有用治療選擇。這種藥物被注射到皮下以撫平臉部皺紋。透明質酸和羥基磷灰石鈣是著名的。真皮填充劑品牌的改進可能有助於市場需求的增加。
成本是擇期手術中需要考慮的因素。真皮填充劑的成本會根據手術中使用的類型和數量而有所不同。此手術的費用還取決於應用皮膚填充劑的從業者的培訓和經驗。真皮填充劑是一種流行的美容手術,可以恢復失去的體積並治療各種老化徵兆。儘管這是一種安全的門診手術,但由於治療成本高昂,預計市場需求將受到限制。
COVID-19大流行對美容皮膚科和美容醫療產業產生了負面影響,該行業在國際上經歷了生產問題和供應鏈中斷。封鎖措施、旅行限制和裁員都導致真皮填充劑的生產、分銷和運輸延遲,導致各個地區短缺和供應有限。此外,在疫情最嚴重的時候,包括整容治療在內的選擇性醫療程序受到嚴格限制。結果,非必要的診所暫時關閉,美容服務的需求大幅下降。
預計可生物分解性部分在預測期內將是最大的部分。這些產品旨在創造溫和、自然的增強效果,同時模仿臉部特徵。它可用於改善嘴唇和臉頰等臉部特徵,填充皺紋和細紋,並增加臉部體積。與永久性填充劑相比,可生物分解性的皮膚填充劑會隨著時間的推移逐漸分解並被身體吸收。這意味著患者可以改變自己的外表,以適應他們不斷變化的需求和偏好。
透明質酸領域預計在預測期內將表現出最高的複合年成長率。深層皺紋、細紋和體積損失只是透明質酸皮膚填充劑可以解決的一些問題。它還可用於改善疤痕和其他皮膚缺陷的外觀,並強調嘴唇和顴骨。透明質酸填充劑有多種配方,可讓醫生根據每位患者的特定需求量身訂做治療方案。
預計北美在預測期內將佔據最大的市場佔有率。這是由於男性越來越受歡迎、永恆美麗的趨勢不斷成長以及對非手術整容手術的需求不斷成長。該地區的居民非常注重美麗和外表吸引力的理想。因此,真皮填充劑作為改善臉部特徵和減少老化症狀的一種方式,需求量很大。
預計亞太地區在預測期內將維持最高的複合年成長率。隨著可支配收入的增加,該地區更多的人可能有能力承擔整容手術的費用。由於該地區是熱門的醫療旅遊目的地,許多人來這裡進行整容手術,該地區的產業蓬勃發展。此外,該地區的美麗理想正在不斷發展,人們越來越關注大嘴唇和高顴骨等特徵。
According to Stratistics MRC, the Global Dermal Fillers Market is accounted for $5.5 billion in 2023 and is expected to reach $10.5 billion by 2030 growing at a CAGR of 9.8% during the forecast period. Dermal fillers are less invasive treatments that employ gel-based materials. These are utilized to enhance the appearance of the facial skin and come in the form of injectables. These treatments contribute to a more youthful appearance by minimizing wrinkles. These procedures are helpful in reducing acne scars and are utilized to improve lips and facial wrinkles.
According to WHO estimates, by 2030, one in every six people in the world will be 60 or older. As per statistics, the geriatric population size will get double from 1 billion in 2020 to 2.1 billion in 2050.
A treatment known as minimally-invasive surgery is one that is carried out with the use of specialized surgical tools and a scope for seeing. It reduces extra fat, volume, and contour while focusing on face abnormalities including fine lines and wrinkles. There is a great demand worldwide for minimally invasive energy-based skin tightening, wrinkle reduction, face sculpting, and skin rejuvenation procedures. Thus, the increasing prevalence of minimally invasive procedures is expected to drive growth in the market.
The ingredients used to make permanent dermal fillers are indigestible to the human body. As a result, the body will probably defend itself, which might result in consequences including infections and the development of biofilms. Furthermore, permanent fillers harm the human body irreversibly and are not removed. A rising number of people's concerns about the negative consequences of using dermal fillers may limit the market's evolution to some extent.
Dermal fillers are compounds that resemble gel and are injected beneath the skin to smooth lines, soften wrinkles, and replenish lost volume. Without requiring surgery or downtime, these fillers are a useful therapeutic option for looking younger. This medication is injected beneath the skin to help plump up wrinkles on the face. This medications come in a variety of forms; the most popular ones are hyaluronic acid and calcium hydroxylapatite, among others. Improvements in dermal filler brands will contribute to increased market demand.
Cost is a factor that is taken into account for elective procedures. Dermal filler costs vary based on the kind and quantity utilized in the procedure. The cost of the procedure also depends on the training and experience of the practitioner applying dermal fillers. Dermal filler is a popular cosmetic operation that may restore lost volume and cure various indications of aging. It is a safe outpatient procedure, but the expensive cost of the treatments is anticipated to limit market demand.
The COVID-19 pandemic had a detrimental influence on the cosmetic dermatology and aesthetic medicine industries, which suffered production issues and supply chain interruptions internationally. Lockdown procedures, travel restrictions, and a smaller labor force all contributed to delays in dermal filler manufacture, distribution, and transit, which in turn resulted in shortages and restricted availability in different areas. Furthermore, at the pandemic's height, there were severe restrictions on elective medical procedures, including beauty treatments. This led to the temporary closure of non-essential clinics and a sharp drop in the demand for cosmetic services.
The biodegradable segment is expected to be the largest during the forecast period. They are intended to create a mild, natural-looking augmentation while imitating the facial features. They can be used to improve facial features like the lips and cheeks, fill in wrinkles and fine lines, and add volume to the face. Biodegradable dermal fillers, in contrast to permanent fillers, are intended to progressively degrade and be absorbed by the body over time. This implies that patients can modify their look to suit their changing demands and tastes.
The hyaluronic acid segment is expected to have the highest CAGR during the forecast period. Deep creases, wrinkles, fine lines, and volume loss are just a few of the issues that can be resolved with hyaluronic acid dermal fillers. They may also be used to improve the look of scars and other skin defects, as well as to accentuate the lips and cheekbones. Because they come in various formulations, practitioners may tailor therapies to the specific requirements of each patient.
North America is projected to hold the largest market share during the forecast period. This is due to males are becoming more popular, there is a growing trend of ageless beauty in the area, and there is an increased need for non-surgical cosmetic operations. The region's populace is very conscious of ideals of beauty and physical attractiveness. Because of this, dermal fillers are in high demand as a way to improve face characteristics and lessen aging symptoms.
Asia Pacific is projected to hold the highest CAGR over the forecast period. More people in the area may afford cosmetic operations as disposable income rises. Due to the region's popularity as a medical tourism destination, many individuals come here for cosmetic procedures-the area industry has grown rapidly. In addition, the region's ideals of beauty are evolving, placing an increasing focus on characteristics like big lips and high cheekbones.
Some of the key players in Dermal Fillers market include Allergan , Anika Therapeutics, Inc., BIOXIS Pharmaceuticals, Elan aesthetics Inc, FillMed Laboratories, Galderma Laboratories, L.P., Merz Pharma, Prollenium Medical Technologies, Teoxane Laboratories, Revance Therapeutics, Inc., Sinclair Pharma, Suneva Medical, Vital Esthetique Laboratories, Contura International ltd., Zimmer Aesthetic and BioPlus Co., Ltd.
In April 2023, Sinclair Pharma announced that it has received European CE mark for Perfectha Lidocaine, a hyaluronic acid dermal filler pre-mixed with lidocaine. This will make the filler more comfortable for patients to receive.
In March 2023, Revance Therapeutics announced that it has submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) for TAO, a hyaluronic acid dermal filler for the correction of moderate to severe facial wrinkles and folds.
In February 2023, Galderma received FDA approval for Restylane Defyne, a hyaluronic acid dermal filler for chin augmentation. This is the first FDA-approved dermal filler specifically for chin augmentation.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.